Amarin Corporation
AMRN
$0.91
Share price
-0.87%
Change (1 day)
-34.53%
Change (1 year)
Categories
Amarin Corporation (AMRN) - Total debt
Total debt on the balance sheet as of December 2023 : $8.73 M
According to Amarin Corporation 's latest financial reports the company's total debt is $8.73 M. A company’s total debt is the sum of all current and non-current debts.
Amarin Corporation - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $8.73 M | -12.76% |
| 2022-12-31 | $10.01 M | 16.78% |
| 2021-12-31 | $8.57 M | -6.3% |
| 2020-12-31 | $9.15 M | -84.64% |
| 2019-12-31 | $59.57 M | -25.86% |
| 2018-12-31 | $80.34 M | -34.49% |
| 2017-12-31 | $0.12 B | 5.33% |
| 2016-12-31 | $0.11 B | -52.08% |
| 2015-12-31 | $0.24 B | 7.11% |
| 2014-12-31 | $0.22 B | -9.26% |
| 2013-12-31 | $0.25 B | 6.85% |
| 2012-12-31 | $0.23 B | 30525.65% |
| 2011-12-31 | $0.76 M | 768.18% |
| 2010-12-31 | $0.08 M | -84.56% |
| 2009-12-31 | $0.57 M | -45.03% |
| 2008-12-31 | $1.03 M | -49.68% |
| 2007-12-31 | $2.06 M | |
| 2005-12-31 | $0.02 M | -98.75% |
| 2004-12-31 | $2 M | -93.65% |
| 2003-12-31 | $31.5 M | -36.05% |
| 2002-12-31 | $49.26 M | -5.18% |
| 2001-12-31 | $51.95 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 AbbVie ABBV | $59.38 B | 679,595.55% | 🇺🇸 USA |
 AstraZeneca AZN | $34.55 B | 395,356.11% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $22.45 B | 256,956.20% | 🇬🇧 UK |
 Alkermes ALKS | $0.37 B | 4,159.87% | 🇮🇪 Ireland |
 Teva Pharmaceutical Industries TEVA | $20.15 B | 230,562.70% | 🇮🇱 Israel |